Share This Page
Drug Price Trends for ADIPEX-P
✉ Email this page to a colleague
Average Pharmacy Cost for ADIPEX-P
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ADIPEX-P 37.5 MG TABLET | 57844-0140-01 | 2.71753 | EACH | 2025-01-01 |
| ADIPEX-P 37.5 MG TABLET | 57844-0140-56 | 2.71753 | EACH | 2025-01-01 |
| ADIPEX-P 37.5 MG TABLET | 57844-0140-01 | 2.48403 | EACH | 2024-12-18 |
| ADIPEX-P 37.5 MG TABLET | 57844-0140-56 | 2.48403 | EACH | 2024-12-18 |
| ADIPEX-P 37.5 MG TABLET | 57844-0140-56 | 2.47971 | EACH | 2024-11-20 |
| ADIPEX-P 37.5 MG TABLET | 57844-0140-01 | 2.47971 | EACH | 2024-11-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Adipex-P
Overview of Adipex-P
Adipex-P, also known as phentermine, is a prescription appetite suppressant used to aid in weight loss. It is part of the anorexiants drug class and is typically prescribed for short-term use as part of a comprehensive weight reduction program that includes dietary changes, behavioral modification, and exercise[1][4].
Market Size and Growth
The anti-obesity drugs market, which includes Adipex-P, is experiencing significant growth. In 2022, the global anti-obesity drugs market was valued at $1,605.36 million and is projected to reach $4,439.34 million by 2032, with a Compound Annual Growth Rate (CAGR) of 10.7%[3].
Drivers of Market Growth
Several factors are driving the growth of the anti-obesity drugs market:
- Increasing Prevalence of Obesity: The rising number of obese individuals globally is a major driver. Obesity is associated with various chronic diseases, such as hypertension, diabetes, and hyperlipidemia, which increases the demand for anti-obesity drugs[3][4].
- Rise in Healthcare Expenditure: Increased healthcare spending in developed countries like the U.S. and Canada is boosting the market. This expenditure includes investments in research and development (R&D) activities by pharmaceutical companies[3].
- Awareness and Clinical Trials: Growing awareness about the severe health implications of obesity and the increase in clinical trials due to higher investments in R&D are also fueling market growth[3].
Regional Market Analysis
The anti-obesity drugs market is analyzed across various regions, including North America, Europe, Asia-Pacific, and Latin America, Middle East, and Africa (LAMEA).
- Asia-Pacific: This region is expected to witness the highest growth rate due to the increasing demand for anti-obesity drugs in countries like India, China, and South Korea. The rise in obesity prevalence and awareness about anti-obesity treatments in these developing countries are key factors[3].
Pricing and Cost Analysis
The cost of Adipex-P can vary significantly depending on the pharmacy and the use of discount cards or coupons.
- Retail Prices: The retail price for Adipex-P 37.5 mg oral tablets can range from $76 to $126 for a supply of 30 tablets, depending on the pharmacy[5].
- Discounted Prices: With the use of discount cards, such as those offered by SingleCare or Drugs.com, the cost can be significantly reduced. For example, a generic version of Adipex-P can cost as low as $8.71 for 30 tablets with a SingleCare coupon[1][5].
Price Projections
Given the market trends and growth drivers, here are some price projections for Adipex-P:
- Short-Term: Prices are likely to remain stable or see a slight decrease due to the availability of generic versions and the use of discount cards. For instance, the cost for a generic phentermine 37.5 mg oral tablet could range from $12 to $20 for a supply of 7 tablets, depending on the pharmacy and discounts available[2][5].
- Long-Term: As the demand for anti-obesity drugs increases, especially in regions like Asia-Pacific, the prices might stabilize or increase slightly. However, the impact of generic competition and discount programs will likely keep prices in check. By 2032, the overall market size is expected to grow, but individual drug prices may not increase proportionally due to competitive pressures and regulatory factors[3].
Competitive Landscape
The anti-obesity drugs market is competitive, with several players investing heavily in R&D to develop new and innovative treatments. This competition, along with the availability of generic versions of drugs like Adipex-P, will continue to influence pricing.
- Generic Competition: The availability of generic phentermine reduces the pricing power of brand-name Adipex-P, making it more affordable for consumers[1][5].
- New Treatments: The development of new anti-obesity drugs could also impact the market share and pricing of existing drugs like Adipex-P. However, these new treatments may also come with higher price tags, potentially maintaining a balance in the market[3].
Challenges and Limitations
Despite the growth projections, there are challenges that could affect the market and pricing of Adipex-P:
- Alternative Therapies: The availability of alternative weight loss therapies, such as lifestyle changes, surgical interventions, and other non-pharmacological treatments, can reduce the demand for anti-obesity drugs[3].
- Side Effects and Safety Concerns: Potential side effects and safety concerns associated with anti-obesity drugs can also impact market growth and pricing. Regulatory scrutiny and consumer awareness about these issues can influence demand and pricing strategies[3][4].
Key Takeaways
- Market Growth: The anti-obesity drugs market, including Adipex-P, is expected to grow significantly by 2032.
- Pricing Stability: Prices for Adipex-P are likely to remain stable or decrease slightly due to generic competition and discount programs.
- Regional Variations: The Asia-Pacific region is expected to drive the highest growth in the anti-obesity drugs market.
- Competitive Landscape: The market is competitive, with ongoing R&D and the availability of generic versions influencing pricing.
FAQs
Q: What is Adipex-P used for? A: Adipex-P (phentermine) is used as a short-term adjunct in a regimen of weight reduction based on exercise, behavioral modification, and caloric restriction for patients with exogenous obesity[4].
Q: How much does Adipex-P cost? A: The retail price for Adipex-P 37.5 mg oral tablets can range from $76 to $126 for a supply of 30 tablets. However, with discount cards, the cost can be reduced to as low as $8.71 for a generic version[1][5].
Q: What are the main drivers of the anti-obesity drugs market? A: The main drivers include the increasing prevalence of obesity, rise in healthcare expenditure, and increased awareness and clinical trials for anti-obesity treatments[3].
Q: Which region is expected to witness the highest growth in the anti-obesity drugs market? A: The Asia-Pacific region is expected to witness the highest growth due to increasing demand and awareness in countries like India, China, and South Korea[3].
Q: Are there any challenges facing the anti-obesity drugs market? A: Yes, challenges include the availability of alternative therapies, potential side effects, and safety concerns associated with anti-obesity drugs[3].
Sources
- SingleCare: Adipex-P Coupons & Prices.
- Drugs.com: Phentermine Prices, Coupons, Copay Cards & Patient Assistance.
- Allied Market Research: Anti-Obesity Drugs Market Size, Share & Growth Report, 2032.
- Drugs.com: Adipex-P: Package Insert / Prescribing Information.
- Drugs.com: Adipex-P Prices, Coupons, Copay Cards & Patient Assistance.
More… ↓
